Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Pharmacological Research|August 1, 1994
Protective effects of BAY U 3405, a thromboxane A2 receptor antagonist, in endotoxin shockD Altavilla, P Canale, F Squadrito, et al.
European Journal of Pharmacology|January 14, 1992
Cloricromene, a coumarine derivative, protects against lethal endotoxin shock in ratsF Squadrito, D Altavilla, G M Campo, et al.
Journal of Cardiovascular Pharmacology|January 1, 1994
Protective effects of L-659,989, a platelet-activating factor receptor antagonist, in myocardial ischemia and reperfusion in ratsM Ioculano, F Squadrito, D Altavilla, et al.
British Journal of Pharmacology|January 1, 1997
The effects of recombinant human granulocyte-colony stimulating factor on vascular dysfunction and splanchnic ischaemia-reperfusion injuryF Squadrito, D Altavilla, G Squadrito, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Protection of ischemic and reperfused rat myocardium by the nonglucocorticoid 21-aminosteroid U-74389G, a new inhibitor of lipid peroxidationG M Campo, F Squadrito, D Altavilla, et al.
European Journal of Pharmacology|November 3, 1995
G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesisD Altavilla, F Squadrito, P Canale, et al.
British Journal of Pharmacology|December 1, 1994
Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shockF Squadrito, D Altavilla, P Canale, et al.
Pageof 4